Stendra

FDA Building 2
Marketing

FDA rebukes Metuchen for 'misleading' Stendra ads

Touting an off-label use is a big no-no in pharma marketing, and that's exactly what's landed Metuchen Pharmaceuticals in trouble with the FDA.
Beth Snyder Bulik Aug 29, 2019 4:03pm
Sanofi

Sanofi wipes its hands of Vivus ED med Stendra

Mar 29, 2017 9:55am
alone

Post-Endo pact, will Vivus market Stendra solo--and should it?

Aug 5, 2016 11:43am